Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent

Catherine Dodé1, Bouke P C Hazenberg, Christophe Pêcheux

  • 1Laboratoire de biochimie et génétique moléculaire, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Abstract

Insights

Familial Mediterranean fever (FMF) and TRAPS are key causes of AA amyloidosis in specific ethnic groups. Genetic testing for MEFV and TNFRSF1A mutations is crucial for managing AA amyloidosis linked to inherited recurrent fevers.

Area of Science:

  • Genetics
  • Internal Medicine
  • Rheumatology

Background:

  • Familial Mediterranean fever (FMF) and tumor necrosis factor receptor superfamily 1A (TNFRSF1A) receptor-associated periodic syndrome (TRAPS) are hereditary fevers causing recurrent inflammation and AA type renal amyloidosis.
  • Genetic mutations in MEFV and TNFRSF1A genes are identified causes for FMF and TRAPS, respectively.

Purpose of the Study:

  • To characterize the genotypes of FMF and TRAPS in 38 unrelated patients with AA amyloidosis and recurrent inflammatory attacks.
  • To investigate the genetic basis of AA amyloidosis in patients with recurrent inflammatory episodes.

Main Methods:

  • Genomic DNA was extracted from 38 patients with AA amyloidosis and recurrent inflammatory attacks.
  • Polymerase chain reaction (PCR) was used to amplify MEFV and TNFRSF1A genes, followed by direct sequencing to identify mutations.

Main Results:

  • Mutations in MEFV or TNFRSF1A genes were identified in 27 out of 38 patients (71%).
  • MEFV mutations were prevalent in Sephardic Jews, Turks, Armenians, and Arabs from the Maghreb, with M694V/M694V being the most common genotype.
  • TNFRSF1A mutations were found in three Caucasian patients.

Conclusions:

  • Familial Mediterranean fever (FMF) is the primary cause of AA amyloidosis in Sephardic Jews and Turks.
  • MEFV and TNFRSF1A mutations were identified in a subset of Arab patients from the Maghreb, suggesting other genetic factors may be involved.
  • The study identified families with AA amyloidosis lacking MEFV or TNFRSF1A mutations, indicating the existence of other genetic causes. Genetic characterization is vital for managing AA amyloidosis associated with inherited recurrent fevers.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...